dbacp06977
General Description
Peptide name : C16-E4Y
Source/Organism : Synthetic
Linear/Cyclic : Linear
Chirality : L
Sequence Information
Sequence : EEEEY
Peptide length: 5
C-terminal modification: Linear
N-terminal modification : Free
Non-natural peptide information:
Activity Information
Assay type : WST-8 assay
Assay time : 24-h
Activity : 50 % cell viability at 0.05 wt %
Cell line : HepG-2
Cancer type : Liver Cancer
Other activity : Anticancer
Physicochemical Properties
Amino acid composition bar chart :
Molecular mass : 697.6445 Dalton
Aliphatic index : 0
Instability index : 203.6
Hydrophobicity (GRAVY) : -3.06
Isoelectric point : 4.05
Charge (pH 7) : -4.1557
Aromaticity : 20
Molar extinction coefficient (cysteine, cystine): (0, 0)
Hydrophobic/hydrophilic ratio : 0
hydrophobic moment : -0.469
Missing amino acid : A,C,D,F,G,H,I,K,L,M,N,P,Q,R,S,T,V,W
Most occurring amino acid : E
Most occurring amino acid frequency : 4
Least occurring amino acid : Y
Least occurring amino acid frequency : 1
Structural Information
3D structure :
Secondary structure fraction (Helix, Turn, Sheet): (80, 0, 20)
SMILES Notation: N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O
Secondary Structure :
| Method | Prediction |
|---|---|
| GOR | HHHHH |
| Chou-Fasman (CF) | CCCCC |
| Neural Network (NN) | CCCCH |
| Joint/Consensus | CCCCC |
Molecular Descriptors and ADMET Properties
Molecular Descriptors: Click here to download
ADMET Properties: Click here to download
Cross Referencing databases
CancerPPD : Not available
ApIAPDB : Not available
CancerPPD2 ID: 7272
Reference
1 : Morita K, et al. In Situ Synthesis of an Anticancer Peptide Amphiphile Using Tyrosine Kinase Overexpressed in Cancer Cells. JACS Au. 2022; 2:2023-2028. doi: 10.1021/jacsau.2c00301
Literature
Paper title : In Situ Synthesis of an Anticancer Peptide Amphiphile Using Tyrosine Kinase Overexpressed in Cancer Cells.
Doi : https://doi.org/10.1021/jacsau.2c00301
Abstract : Cell-selective killing using molecular self-assemblies is an emerging concept for cancer therapy. Reported molecular self-assemblies are triggered by hydrolysis of well-designed molecules inside or outside cancer cells. This hydrolysis can occur in cancer and normal cells because of the abundance of water in living systems. Here, we report the in situ synthesis of a self-assembling molecule using a tyrosine kinase overexpressed in cancer cells. We designed a tyrosine-containing peptide amphiphile (C16-E4Y) that is transformed into a phosphorylated peptide amphiphile (C16-E4pY) by the overexpressed tyrosine kinase. Phosphorylation of C16-E4Y promoted self-assembly to form nanofibers in cancer cells. C16-E4Y exhibited selective cytotoxicity toward cancer cells overexpressing the tyrosine kinase. Self-assembled C16-E4pY induced endoplasmic reticulum stress that caused apoptotic cell death. Animal experiments revealed that C16-E4Y has antitumor activity. These results show that an enzyme overexpressed in cancer cells is available for intracellular synthesis of an antitumor self-assembling drug that is cell-selective.